patients receiving IVT and those treated with MT alone. [1] [2] [3] [4] [5] Furthermore, a pooled analysis of SWIFT and STAR studies (Solitaire Flow Restoration Thrombectomy for Acute Revascularization) indicated that IVT before MT in patients with an acute ischemic stroke because of a large-vessel occlusion (LVO) did not provide an additional clinical benefit over MT alone. 6 However, in these trials, patients treated with MT alone were IVT ineligible, eventually putting them at a higher risk of unfavorable outcome.
Data on outcome of IVT eligible patients treated with direct MT are scarce. Two retrospective studies compared outcome of IVT eligible patients who underwent direct MT with bridging patients, but numbers in both studies were too small to perform subgroup analyses of patients with an acute occlusion of the internal carotid artery (ICA). 7, 8 This subgroup is of special interest because they usually present with major strokes with an increased risk of intracerebral hemorrhage (ICH). We therefore aimed to pool individual patient data of these 2 registries to compare safety (bleeding complications) and efficacy (clinical outcomes) of direct MT versus bridging thrombolysis.
Patients and Methods

Study Design and Population
A limited anonymized data set to this article will be available on request by Professor Urs Fischer, corresponding author of this article. This analysis is based on the Essen and Bernese stroke registries. For this study, we analyzed individual patient data from all consecutive acute ischemic stroke patients treated with endovascular therapy (EVT) between June 2012 and August 2013 in Essen and February 2009 and August 2014 in Bern (Essen: 312 patients, Bern: 1222 patients). Patients were included if they were treated with EVT and had an LVO in the anterior circulation, that is, occlusion of the ICA, the M1 or M2 segment of the middle cerebral artery. We excluded all patients treated with IVT only or intra-arterial pharmacological treatment, with contraindications for IVT and those lost for followup or with missing key outcome data at 3 months. A flow chart is given in Figure I in the online-only Data Supplement. Two hundred forty-nine patients were treated with bridging thrombolysis, and 111 patients underwent direct MT. All these 111 patients from the direct MT group would have qualified for bridging thrombolysis. All patients were treated by clinicians as part of their clinical routine care, and none of the patients treated in the 2 institutions were treated as part of a study protocol or with the intention to perform a research study. We also performed subgroup analyses of patients with ICA occlusions.
Baseline characteristics (ie, demographic data, vascular risk factors, laboratory findings), treatment modalities, and time from symptom onset to diagnosis and treatment were recorded in both registries. Stroke severity was assessed using the National Institute of Health Stroke Scale (NIHSS) score. 9 All patients underwent computed tomographic or magnetic resonance imaging to rule out intracranial hemorrhage and computed tomographic angiography or magnetic resonance angiography to assess the site of vessel occlusion. The general approach to perform thrombolysis and thrombectomy in both centers has been described previously. 7, 8 In summary, IVT and EVT were performed according to the international and institutional guidelines, and the bridging group received either full-dose (0.9 mL/kg body weight) or two-thirds dose (0.6 mL/kg body weight) intravenous tPA within 4.5 hours after symptom onset. EVT was performed if (1) diagnosis of ischemic stroke was established; (2) baseline NIHSS score was ≥4 points or isolated aphasia or hemianopia was present; (3) hemorrhage on cranial computed tomographic or magnetic resonance imaging was excluded; (4) vessel occlusion correlated with the neurological deficit; (5) symptom duration was not longer than 24 hours; and (6) no individual clinical or premorbid conditions or laboratory findings advised against thrombolysis. 7, 8 However, final treatment decision was based at the discretion of the neurologists and neuroradiologists on call. In some cases of LVO, the team decided against bridging thrombolysis and performed direct MT. Digital subtraction angiography was performed via transfemoral approach. Endovascular recanalization procedures consisted of a combination of several approaches depending on occlusion pattern and operator preference: mechanical recanalization using thromboaspiration and stent retrievers and placement of extracranial stents. The interventional neuroradiologists decided together with the stroke neurologist on MT and-if necessary-stenting of the extracranial ICA. Twenty-four hours after treatment, or in any case of clinical deterioration, a computed tomographic or magnetic resonance imaging scan was performed. Symptomatic ICH (sICH) and asymptomatic ICH (aICH) were classified according to the ECASS III study (The European Cooperative Acute Stroke Study) protocol. 10, 11 Clinical outcome was prospectively assessed 3 months after the stroke using the modified Rankin Scale (mRS). 12 In patients from the Essen cohort, functional outcome was assessed at 3 months with mailed questionnaires by a blinded investigator of the Institute of Epidemiology and Social Medicine at the University of Münster. For patients unable to respond to the questionnaire, mRS status was assessed by phone by a local investigator. In Bern, all patients were invited for a 3-month outpatient visit. If patients were not able to attend the visit, mRS was assessed by a structured phone interview. The study was performed according to the ethics committees of the Chambers of Physicians of Westphalia and North Rhine in Germany, and according to the ethical guidelines of the Canton of Bern and with corresponding permission.
Statistical Analysis
We performed a pooled analysis of the 2 centers because of the broad similarity of background characteristics and outcomes in the 2 centers and nonsignificant tests for the treatment-by-center interaction in models for key outcomes: 0.61 for mRS, 0.79 for functional independence, and 0.15 for death in multiple logistic or linear regression models with additional adjustments for age, baseline NIHSS, history of coronary heart disease, time to diagnosis, presence of ICA lesions, and the propensity score for bridging or mechanical-only treatment. We compared baseline characteristics, treatment data, and outcomes between 249 bridging patients and 111 patients treated with direct MT who would have qualified for bridging therapy. Differences between the 2 groups were assessed using Fisher exact test for categorical variables and the Wilcoxon rank-sum test for continuous variables. Complete reperfusion was defined as thrombolysis in cerebral infarction score 2b-3. Functional independence was defined as mRS score of 0 to 2 and excellent clinical outcome as mRS score of 0 to 1. In our primary analysis, we performed a 1:1 matched-pair analysis and compared patients from the direct MT group with matched patients from the bridging group using McNemar test (categorical variables) and the Wilcoxon signed-rank test (continuous variables). Matching (1:1) was performed using a multivariate genetic algorithm 13 taking the following baseline variables into account: age, sex, NIHSS, time from symptom onset to diagnosis, hypertension, and thrombus location (ICA or middle cerebral artery), and we also performed supportive analyses based on 1:2 matching. Further supportive analyses used the propensity score, computed based on a multiple logistic regression model accounting for additional explanatory variables (Table I in the online-only Data Supplement). The propensity score was used to create alternative matched pairs and a covariate in multiple linear and logistic regression models of the outcomes evaluating the effect of the treatment choice. Subgroup analyses in patients with ICA occlusions were performed. Two-sided P values <0.05 were considered statistically significant. Analyses were performed using R (version 3.1.2-R Core Team [2014] . R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria).
Results
Baseline characteristics of the 111 patients from the MT group without contraindications for IVT and 249 patients treated with bridging thrombolysis are shown in Table 1 .
Stroke
December 2017
Univariate Between-Group Comparisons
Baseline characteristics between both groups did not differ, except for higher rates of coronary heart disease ( 
Matched-Pairs Analysis and Supportive Models for All Patients
A total of 103 direct MT patients were evaluable for the matched-pairs analysis with the multivariate method. Results are shown in (Tables II and III in 
Matched-Pairs Analysis and Supportive Models for Patients With ICA Occlusions
Results were similar for patients with an ICA occlusion except for a significantly higher mortality rate in the bridging (54.3%) compared with the MT (28.3%) group (Table 3) . Additional analyses based on 1:2 matching and propensity score matching supported the key findings (Tables IV and V in the onlineonly Data Supplement). Rates of aICH tended to be higher in the bridging cohort than in the direct MT group, however, gaining statistical significance in the propensity score matching group only.
Discussion
This individual patient data analysis based on 2 registries compared bridging therapy with direct MT in IVT eligible patients. We could not find any difference in mortality, functional outcome, recanalization rates, or bleeding complications in IVT eligible stroke patients with LVO in the anterior circulation; however, mortality in patients with ICA occlusion treated with direct MT was lower than after bridging thrombolysis. There are several observational studies comparing direct MT in IVT ineligible patients with bridging thrombolysis. Some of these studies suggested that pretreatment with IVT before MT may increase recanalization rates and facilitate the endovascular procedure; however, there was a considerable between-study variance. [14] [15] [16] [17] [18] [19] However, these findings could not be supported by post hoc analyses of recent randomized controlled trials, neither in a pooled post hoc analysis of SWIFT-PRIME and STAR nor in a post hoc analysis of MR CLEAN. 6, 20 Furthermore, a recent metaanalysis of 5 randomized controlled trials suggested that the treatment effect size of MT does not differ between patients receiving IVT and those treated with MT alone. 1 These findings were challenged by a meta-analysis, including data from THRACE (Mechanical Thrombectomy After Intravenous Alteplase Versus Alteplase Alone After Stroke), PISTE (The Pragmatic Ischaemic Stroke Thrombectomy Evaluation), and THERAPY (The Randomized, Concurrent Controlled Trial to Assess the Penumbra System's Safety and Effectiveness in the Treatment of Acute Stroke), [21] [22] [23] showing that patients receiving IVT before MT had lower rates of death or severe dependency at 3 months compared with patients treated with MT alone. 24 A further meta-analysis published in Stroke concluded that bridging therapy is superior to direct MT. 25 However, the shortcoming of both comparisons was the inclusion of IVT eligible and ineligible patients. IVT ineligible patients are inherently different from IVT eligible patients, and it is well known that patients treated later and patients with comorbidities, especially patients with anticoagulation treatment, have a genuine poorer outcome than IVT eligible patients. The difference in outcome is therefore likely to be caused by group aICH indicates asymptomatic intracerebral hemorrhage; ICA, internal carotid artery; IVT, intravenous thrombolysis; M1/M2, M1/M2 segment of the middle cerebral artery; mRS, modified Rankin Scale; MT, mechanical thrombectomy; NIHSS, National Institute of Health Stroke Scale; sICH, symptomatic intracerebral hemorrhage; and TICI, thrombolysis in cerebral infarction.
*Data are presented as number (percentage) of patients unless otherwise indicated.
†Score of 0 to 1 indicates excellent outcomes; 0 to 2, good outcomes.
Figure.
Matched case-control analysis (multivariate matching): modified Rankin Scale (mRS) after 3 months.
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imbalances in baseline characteristics introduced be eligibility criteria rather than different treatment effect sizes. In our individual patient data comparison of bridging therapy with direct MT, we included IVT eligible patients only. Some data of these patients have been published in previous reports; however, because of the small simple size and because of the local setting, it was difficult to translate the data in a general setting and to perform subgroup analysis in patients with ICA occlusion. We could not observe any increase in mortality when withholding IVT before MT: neither in univariate analysis nor in multivariate and propensity score matching, there was any difference in mortality between both groups. In the subset of patients with ICA occlusion, there was no difference in the univariate comparison, but in the multivariate matching analysis, mortality rate was significantly lower in the direct MT group (P=0.01). This finding was confirmed after 2:1 matching and propensity score matching. The reason for the higher mortality in patients with ICA occlusion after pretreatment with intravenous tPA remains unknown. One potential explanation could be the higher risk of sICH and aICH in patients with large strokes and involvement of the basal ganglia, pretreated with intravenous tPA. However, rates of sICH did not differ between the 2 groups, and rates of aICH tended to be higher in the bridging cohort than in the direct MT group, however, gaining statistical significance in the propensity score matching group only. A further explanation could be the lower rates of recanalization in patients with ICA occlusion.
Intervals from symptom onset to EVT in the MT group were shorter probably caused by prehospital selection. In secondary referred patients from other hospitals, IVT is often already administered, whereas by directly referred stroke patients, skipping of IVT was more often performed. Furthermore, intervals from image to EVT were also shorter in the MT group. This could be explained in part because of secondary referred patients from other hospitals that perform the initial imaging but not IVT. Rates of sICH did not differ between both groups in all main and subgroup analyses; however, there was a trend of lower aICH in the direct MT group compared with the bridging cohort in univariate analysis (P=0.07). The same trend could also be observed in multivariate and propensity score matching, however, not gaining statistical significance, most likely because of the small sample size. In the publication of BroegMorvay et al, 7 we also reported rates of systemic bleeding complications. However, these data were not registered in the Essen registry, and, therefore, a comparison was no longer possible.
Functional outcome was also similar in both groups: there was no difference in excellent (mRS score of 0-1) or favorable (mRS score of 0-2) outcome neither in univariate and matching analyses nor in subgroup analysis of ICA occlusions. It has been hypothesized that IVT before MT may increase recanalization rates by softening the thrombus. We could not observe any differences in successful reperfusion (thrombolysis in cerebral infarction 2b-3). Rates of vessels, which could not be recanalyzed (thrombolysis in cerebral infarction 0-1) did not differ between both groups, neither in univariate nor in multivariate analyses (Tables 1 through 3; Tables I through V in the online-only Data  Supplement) . However, in this analysis, we did not include patients who received intravenous tPA and had a recanalyzed vessel at the time of angiography because the main focus of our article was to compare endovascular-treated patients with and without intravenous tPA pretreatment. However, we analyzed recanalization rates before angiography in a previous study from the Bernese cohort, and recanalization rates were dependent on the site of vessel occlusion and the interval between start of intravenous tPA and start of the endovascular procedure. 26 Our study has several limitations: this is a retrospective, nonrandomized analysis of 2 hospital registries with different time frames. Most importantly, there is a potential selection bias resulting from assignment to bridging thrombolysis or direct MT by consensus rather than randomization. The reasons not to provide intravenous tPA to potential candidates for bridging thrombolysis in IVT eligible candidates were not recorded in the registries, but were mainly a suspicion of large thrombi, but also borderline coagulation status, vascular encephalopathy on imaging, time window close to 4.5 hours, etc. This is a major limitation of our article, which we could not overcome because of the retrospective nature. Furthermore, we excluded patients who received intra-arterial thrombolysis in both groups, which Early CT Score), time point of start of IVT, and collaterals was not recorded in both registries, and, therefore, a comparison was not possible. Furthermore, information on new infarcts on follow-up imaging was not available, given the retrospective nature of our analysis. Finally, the exact cause of death was not registered, and, therefore, the exact reason for the higher mortality in the ICA subgroup remains unclear.
In conclusion in this matched-pair analysis based on 2 large registries, there was no difference in outcome in IVT eligible patients with LVO anterior circulation stroke treated with direct mechanical intervention compared with those treated with bridging thrombolysis except for a higher mortality in patients with ICA occlusions. The SWIFT DIRECT (Solitaire With the Intention for Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire Stent-Retriever Thrombectomy in Acute Anterior Circulation Stroke; https://clinicaltrials.gov/ ct2/show/NCT03192332) will assess whether subjects experiencing an acute ischemic stroke because of LVO in the anterior circulation who are referred to a stroke center with endovascular facilities and who are candidates for intravenous tPA will have noninferior functional outcome at 90 days when directly treated with MT alone compared with subjects treated with intravenous tPA plus MT.
